The drug integrated polymer fibers market is projected to grow from USD 89.9 million in 2025 to USD 171.9 million by 2035, at a CAGR of 6.7%. Polylactic Acid (PLA) will dominate with a 35.7% market share, while drug delivery will lead the application segment with a 29.4% share.